Compass Pathways reported operating expenses of $48.4 million, slightly above Canaccord's estimate of $48 million. Kulkarni highlighted that Compass Pathways is nearing completion of its COMP005 Phase ...

Compass Pathways Plc (NASDAQ: CMPS) stock has reached a new 52-week low, touching down at $3.85. This latest price point marks a significant downturn for the company, which specializes in mental ...

Newly created role of Chief Patient Officer reinforces Compass' vision of working to achieve broad and equitable access to COMP360, if approved Compass Pathways plc (Nasdaq: CMPS) ("Compass"), a ...

COMPASS Pathways plc (NASDAQ:CMPS) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, COMPASS Pathways plc (NASDAQ:CMPS) has a ‘Buy’ or equivalent rating from the majority of ...

LONDON & NEW YORK, May 08, 2025--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its ...

LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced ...

View source version on businesswire.com: https://www.businesswire.com/news/home/20251104736485/en/ ...

LONDON & NEW YORK, January 10, 2025--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental ...

Compass management will host a conference call at 8:00 am ET (1:00 pm UK) Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the first ...

Q2 2025 Management View Kabir Kumar Nath, CEO, announced the appointment of Justin Gover, former CEO of GW Pharmaceuticals, to the Board of Directors, highlighting his experience with "Epidiolex, the ...

Compass Pathways Limited (NASDAQ:CMPS), a pioneering force in the mental health care sector with a market capitalization of $287 million, is navigating a complex landscape as it develops its flagship ...